HealthQuill Liver
Madrigal Pharmaceuticals EU Limited's therapy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) got a conditional marketing authorisation in the European Union. 
Drugs Health Medical

Madrigal’s therapy to treat MASH in adults gets EU’s initial nod

HQ Team June 22, 2025: Madrigal Pharmaceuticals EU Limited’s therapy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) got a conditional marketing.

Read More
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood cancer therapy.
Drugs Health Pharma

J&J seeks approval for its blood cancer therapy in US, European Union

Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood.

Read More
Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past eight years, a study reveals.
Drugs Health Pharma

‘Shard-like plastic remnants’ of varying sizes amass in the brain: UNM

Environmental micro and nanoplastics (MNPs) accumulate in the human brain and total mass concentrations have risen by more than 50% in the past.

Read More